These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12515085)

  • 1. Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy.
    See RF; Rao NA
    Ophthalmol Clin North Am; 2002 Dec; 15(4):529-36, viii. PubMed ID: 12515085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
    Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
    Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM
    JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF; Garcia RA; Mendoza AJ
    Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of CMV retinitis in the era of highly active antiretroviral therapy.
    Jouan M; Katlama C
    Int J Antimicrob Agents; 1999 Sep; 13(1):1-7. PubMed ID: 10563398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
    JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stopping secondary prevention in AIDS patients with inactive CMV retinitis treated with HAART (highly active antiretroviral therapy)].
    Best J; Althaus C; Kersten A; Theisen A; Gantke B
    Ophthalmologe; 2000 Aug; 97(8):574-6. PubMed ID: 10994337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART).
    Roels P
    Optometry; 2004 Oct; 75(10):624-8. PubMed ID: 15508863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
    Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
    Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active cytomegalovirus retinitis after the start of antiretroviral therapy.
    Heiden D; Tun N; Smithuis FN; Keenan JD; Oldenburg CE; Holland GN; Drew WL
    Br J Ophthalmol; 2019 Feb; 103(2):157-160. PubMed ID: 30196272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC; Karavellas MP; Torriani FJ; Morse LS; Smith IL; Reed JB; Freeman WR
    Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
    Jabs DA; Van Natta ML; Thorne JE; Weinberg DV; Meredith TA; Kuppermann BD; Sepkowitz K; Li HK;
    Ophthalmology; 2004 Dec; 111(12):2224-31. PubMed ID: 15582078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL; Raboud J; Angel JB; Mazzulli T; Shen S; Casciaro L; Young CD; Moussa G; Gough K; Rachlis A; Hopkins J
    HIV Clin Trials; 2006; 7(1):1-9. PubMed ID: 16632459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF; Mendoza AJ; Ferretti Y
    Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV after HAART.
    Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994).
    Holland GN; Vaudaux JD; Jeng SM; Yu F; Goldenberg DT; Folz IC; Cumberland WG; McCannel CA; Helm CJ; Hardy WD;
    Am J Ophthalmol; 2008 Jan; 145(1):5-11. PubMed ID: 18154750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Jabs DA; Van Natta ML; Kempen JH; Reed Pavan P; Lim JI; Murphy RL; Hubbard LD
    Am J Ophthalmol; 2002 Jan; 133(1):48-61. PubMed ID: 11755839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR; Baldassano VF; Whitcup SM
    Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.